Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Hospital charity launches research project into ovarian and breast cancer

  • Comment

Research into treating early stage ovarian and breast cancer is due to begin at a hospital charity.

The Myrtle Peach Fund has awarded a research team at Cranfield University£15,000 for developing gynaecological services and to help patients who are at risk from, or have been treated for, cervical or ovarian cancer.

The project will focus on whether cells of the immune system can be generated in the laboratory from stem cells.

Professor Christopher B-Lynch, obstetrics and gynaecology consultant and chair of the Myrtle Peach Fund, said: 'The sooner ovarian cancer is diagnosed, the easier it is to treat. If it's caught in the early stage-one phase, up to 95% of women will live for more than five years.'

It is hoped that the results of the research will also be of help in the treatment of early stage breast cancer and ovarian cancer sufferers, as well as in reducing the risk of infection following major surgery.

The UK has one of the highest incidences of ovarian cancer in Europe, with about 6,800 women diagnosed with it in the UK each year.

Ovarian is the fifth most common women's cancer after breast, bowel, lung and womb cancer.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs